Core Insights - Strata Critical Medical, Inc. reported a significant increase in revenue and gross profit for Q4 2025, with total revenue rising 83.5% year-over-year to $66.8 million, driven by strong performance in both Logistics and Clinical segments [3][10] - The company has raised its revenue guidance for full year 2026 to between $260 million and $275 million, along with Adjusted EBITDA guidance of $29 million to $33 million, reflecting confidence in continued growth [3][12] Financial Performance - Total revenue for Q4 2025 was $66.8 million, compared to $36.4 million in Q4 2024, marking an 83.5% increase [10] - Logistics revenue increased by 35.3% year-over-year to $49.2 million, while Clinical revenue reached $17.6 million, significantly up from $2.8 million in Q3 2025 [10] - Gross profit for Q4 2025 was $14.4 million, a 90.0% increase from $7.6 million in the prior year, with a gross margin of 21.6% [10][21] - The net loss from continuing operations decreased to $(5.4) million in Q4 2025 from $(7.4) million in Q4 2024, indicating improved operational efficiency [10][21] Segment Performance - The Logistics segment reported a gross profit of $10.6 million, up 39.5% year-over-year, while the Clinical segment achieved a gross profit of $3.8 million, reflecting a strong contribution from the recently acquired Keystone business [10][21] - The acquisition of Keystone has been beneficial, contributing to over 40% of sequential Logistics revenue growth in Q4 2025 [8] Strategic Outlook - The company is focusing on expanding its acquisition pipeline, with smaller competitors expressing interest in joining forces, which is expected to enhance growth opportunities [8] - Strata is well-positioned to capitalize on evolving regulatory environments that prioritize efficiency in organ transplantation, particularly with a customer base that includes high-performing transplant centers [8][9] Cash Flow and Capital Management - Strata ended FY 2025 with $61.2 million in cash and short-term investments, providing a solid foundation for future growth initiatives [15] - The company has closed a $30 million asset-backed credit facility with JP Morgan, which can be increased to $50 million, supporting its M&A strategy [15]

Group 1 - Strata Critical Medical will release its financial results for Q4 2025 on March 3, 2026, before market opens [1] - A conference call will be held on the same day at 8:00 am Eastern Time, hosted by Co-CEOs Will Heyburn and Melissa Tomkiel, including a Q&A session [1] - The company is a provider of time-critical logistics and medical services to the U.S. healthcare industry, operating a large air transport and surgical services network [3] Group 2 - Strata's core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry [4] - The company also offers perfusion staffing and equipment solutions for cardiovascular surgery centers under the Trinity Medical Solutions and Keystone Perfusion brands [4] - More information about the company can be found on its website [4]

Core Insights - Strata Critical Medical will release its financial results for Q3 2025 on November 10, 2025, before market opening, followed by a conference call at 8:00 am Eastern Time [1] - The conference call will be hosted by the Co-CEOs and will include a Q&A session for participants [1] Company Overview - Strata Critical Medical is a provider of time-critical logistics and medical services to the U.S. healthcare industry, operating one of the largest air transport and surgical services networks for transplant hospitals and organ procurement organizations [3] - The company offers an integrated "one call" solution for donor organ recovery, which includes air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry [4] Services Offered - Core services include air and ground logistics, surgical organ recovery, organ placement, and perfusion staffing and equipment solutions for cardiovascular surgery centers, marketed under the Trinity Medical Solutions and Keystone Perfusion brands [4]

Company Overview - Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the U.S. healthcare industry, operating one of the largest air transport and surgical services networks for transplant hospitals and organ procurement organizations [3][4] - The company offers an integrated "one call" solution for donor organ recovery, which includes air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry [4] Upcoming Event - Strata will hold an Investor Day at the Nasdaq MarketSite in New York City on November 17th, 2025, starting at 2:00 PM ET, featuring presentations by the management team [1] - Investors and analysts can register for the event on Strata's Investor Relations website, with a live video webcast and presentation materials available on the day of the event [2]